Non-invasive Prenatal Testing
Enhance maternal and fetal heath using noninvasive prenatal testing
Non-invasive prenatal testing (NIPT) is a highly precise and reliable screening test for detecting the most common chromosomal disorders in a baby before birth. It is an advanced technology that can screen for Trisomy 21 (Down syndrome), Trisomy 18 (Edwards syndrome), Trisomy 13 (Patau syndrome), and sex chromosome abnormalities with unparalleled accuracy. Moreover, it can screen for other chromosomal disorders such as Trisomy 9, 16, and 22, along with deletion syndromes like Cri du Chat (5p-), 1 p36, 2q33.1, Prader-Willi/Angelman (15q11.2), 16p12.2, Jacobsen (11q23), DiGeorge Syndrome II (10p13-14), and a genetic disorder known as VanderWoude (1q32.2). NIPT is a non-invasive, safe, and reliable procedure that poses no risk to the mother or the fetus, and it can be performed as early as 11 weeks into the pregnancy.
Testing options
Testing Options
This testing service has not been cleared or approved by the U.S. Food and Drug Administration. Testing services may not be licensed in accordance with the laws in all countries. The availability of specific test offerings is dependent upon laboratory location. The content on this page is provided for informational purposes only, not as medical advice. It is not intended to substitute the consultation, diagnosis, and/or treatment provided by a qualified licensed physician or other medical professionals.